---
schema_version: "secwatch.filing_event.v1"
accession: "0001048477-25-000098"
form_type: "8-K"
ticker: "BMRN"
cik: "0001048477"
company_name: "BIOMARIN PHARMACEUTICAL INC"
filed_at: "2025-08-11T23:59:59+00:00"
generated_at: "2026-05-17T15:07:03.309295+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# BioMarin Chief Accounting Officer Erin Burkhart resigns; CFO to serve as interim principal accounting officer

## Summary
- Erin Burkhart notified her resignation as Chief Accounting Officer, effective September 2, 2025; departure is voluntary with no disagreement.
- BioMarin will conduct a search for a successor; if none is appointed by the Effective Date, CFO Brian Mueller will serve as principal accounting officer.
- Mueller will remain Executive VP and CFO with no additional compensation or adjustments for assuming the principal accounting officer duties.

## SEC filing metadata
- accession: 0001048477-25-000098
- form_type: 8-K
- ticker: BMRN
- cik: 0001048477
- company_name: BIOMARIN PHARMACEUTICAL INC
- filed_at: 2025-08-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1048477/000104847725000098/0001048477-25-000098-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1048477/000104847725000098/bmrn-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001048477-25-000098
- JSON: https://secwatch.observer/filing/0001048477-25-000098.json
- Plain text: https://secwatch.observer/filing/0001048477-25-000098.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.